Lv71
4960 积分 2022-03-06 加入
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
5天前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
7天前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
7天前
已完结
Two for one: candidate obesity drug boosts energy use and curbs calorie intake
9天前
已完结
NK2R control of energy expenditure and feeding to treat metabolic diseases
9天前
已完结
The Phase 3 RESILIENT Study: Taldefgrobep Alfa in Spinal Muscular Atrophy (P2-11.008)
11天前
已关闭
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
14天前
已完结
Retinoblastoma Origins and Destinations
18天前
已完结
Retinoblastoma
18天前
已完结
Role of MYCN in Retinoblastoma: A Review of Current Literature
18天前
已完结
皖公网安备34019202002308
